The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Tablets (ODT) Platform Market Research Report 2025
Synopsis
The Orally Disintegrating Tablets (ODT) platform is an advanced pharmaceutical dosage form designed to dissolve or disintegrate rapidly in the mouth without the need for water, offering enhanced patient convenience and compliance. ODTs typically utilize superdisintegrants and other excipients to promote rapid disintegration upon contact with saliva, facilitating quick absorption of the active pharmaceutical ingredient through the oral mucosa. This platform enables the development of fast-dissolving tablets that provide a pleasant mouthfeel, ease of administration, and potentially faster onset of action compared to conventional oral dosage forms. ODT technology is particularly beneficial for patients who have difficulty swallowing tablets or capsules, including pediatric, geriatric, and psychiatric populations, and offers advantages in terms of dosing accuracy, patient adherence, and improved bioavailability of the drug.
The global Orally Disintegrating Tablets (ODT) Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Orally Disintegrating Tablets (ODT) Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Orally Disintegrating Tablets (ODT) Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Orally Disintegrating Tablets (ODT) Platform include Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablets (ODT) Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablets (ODT) Platform.
The Orally Disintegrating Tablets (ODT) Platform market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Orally Disintegrating Tablets (ODT) Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablets (ODT) Platform manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
Roquette
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF
Adare Pharma
Astellas Pharma
Akina
Vitaquest
Segment by Type
Below Ten Seconds
Ten Seconds and Above
Segment by Application
Pharmaceutical
Nutraceuticals
Chewable Vitamin
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablets (ODT) Platform manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablets (ODT) Platform in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Orally Disintegrating Tablets (ODT) platform is an advanced pharmaceutical dosage form designed to dissolve or disintegrate rapidly in the mouth without the need for water, offering enhanced patient convenience and compliance. ODTs typically utilize superdisintegrants and other excipients to promote rapid disintegration upon contact with saliva, facilitating quick absorption of the active pharmaceutical ingredient through the oral mucosa. This platform enables the development of fast-dissolving tablets that provide a pleasant mouthfeel, ease of administration, and potentially faster onset of action compared to conventional oral dosage forms. ODT technology is particularly beneficial for patients who have difficulty swallowing tablets or capsules, including pediatric, geriatric, and psychiatric populations, and offers advantages in terms of dosing accuracy, patient adherence, and improved bioavailability of the drug.
The global Orally Disintegrating Tablets (ODT) Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Orally Disintegrating Tablets (ODT) Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Orally Disintegrating Tablets (ODT) Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Orally Disintegrating Tablets (ODT) Platform include Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, JRS Pharma, Fuji Chemical, Merck, Galvita, DAICEL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablets (ODT) Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablets (ODT) Platform.
The Orally Disintegrating Tablets (ODT) Platform market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Orally Disintegrating Tablets (ODT) Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablets (ODT) Platform manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
Roquette
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF
Adare Pharma
Astellas Pharma
Akina
Vitaquest
Segment by Type
Below Ten Seconds
Ten Seconds and Above
Segment by Application
Pharmaceutical
Nutraceuticals
Chewable Vitamin
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablets (ODT) Platform manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablets (ODT) Platform in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Orally Disintegrating Tablets (ODT) Platform Market Overview
1.1 Product Definition
1.2 Orally Disintegrating Tablets (ODT) Platform by Type
1.2.1 Global Orally Disintegrating Tablets (ODT) Platform Market Value Comparison by Type (2024-2030)
1.2.2 Below Ten Seconds
1.2.3 Ten Seconds and Above
1.3 Orally Disintegrating Tablets (ODT) Platform by Application
1.3.1 Global Orally Disintegrating Tablets (ODT) Platform Market Value by Application (2024-2030)
1.3.2 Pharmaceutical
1.3.3 Nutraceuticals
1.3.4 Chewable Vitamin
1.4 Global Orally Disintegrating Tablets (ODT) Platform Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablets (ODT) Platform Revenue 2019-2030
1.4.2 Global Orally Disintegrating Tablets (ODT) Platform Sales 2019-2030
1.4.3 Global Orally Disintegrating Tablets (ODT) Platform Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablets (ODT) Platform Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orally Disintegrating Tablets (ODT) Platform Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Orally Disintegrating Tablets (ODT) Platform, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orally Disintegrating Tablets (ODT) Platform, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablets (ODT) Platform, Product Type & Application
2.7 Global Key Manufacturers of Orally Disintegrating Tablets (ODT) Platform, Date of Enter into This Industry
2.8 Global Orally Disintegrating Tablets (ODT) Platform Market Competitive Situation and Trends
2.8.1 Global Orally Disintegrating Tablets (ODT) Platform Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Orally Disintegrating Tablets (ODT) Platform Players Market Share by Revenue
2.8.3 Global Orally Disintegrating Tablets (ODT) Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Orally Disintegrating Tablets (ODT) Platform Market Scenario by Region
3.1 Global Orally Disintegrating Tablets (ODT) Platform Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orally Disintegrating Tablets (ODT) Platform Sales by Region: 2019-2030
3.2.1 Global Orally Disintegrating Tablets (ODT) Platform Sales by Region: 2019-2024
3.2.2 Global Orally Disintegrating Tablets (ODT) Platform Sales by Region: 2025-2030
3.3 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Region: 2019-2030
3.3.1 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Region: 2019-2024
3.3.2 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Region: 2025-2030
3.4 North America Orally Disintegrating Tablets (ODT) Platform Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablets (ODT) Platform Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2030)
3.4.3 North America Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablets (ODT) Platform Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablets (ODT) Platform Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2030)
3.5.3 Europe Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablets (ODT) Platform Market Facts & Figures by Region
3.6.1 Asia Pacific Orally Disintegrating Tablets (ODT) Platform Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orally Disintegrating Tablets (ODT) Platform Sales by Region (2019-2030)
3.6.3 Asia Pacific Orally Disintegrating Tablets (ODT) Platform Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Orally Disintegrating Tablets (ODT) Platform Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablets (ODT) Platform Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2030)
3.7.3 Latin America Orally Disintegrating Tablets (ODT) Platform Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orally Disintegrating Tablets (ODT) Platform Sales by Type (2019-2030)
4.1.1 Global Orally Disintegrating Tablets (ODT) Platform Sales by Type (2019-2024)
4.1.2 Global Orally Disintegrating Tablets (ODT) Platform Sales by Type (2025-2030)
4.1.3 Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Type (2019-2030)
4.2 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Type (2019-2030)
4.2.1 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Type (2019-2024)
4.2.2 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Type (2025-2030)
4.2.3 Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Type (2019-2030)
4.3 Global Orally Disintegrating Tablets (ODT) Platform Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orally Disintegrating Tablets (ODT) Platform Sales by Application (2019-2030)
5.1.1 Global Orally Disintegrating Tablets (ODT) Platform Sales by Application (2019-2024)
5.1.2 Global Orally Disintegrating Tablets (ODT) Platform Sales by Application (2025-2030)
5.1.3 Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Application (2019-2030)
5.2 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Application (2019-2030)
5.2.1 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Application (2019-2024)
5.2.2 Global Orally Disintegrating Tablets (ODT) Platform Revenue by Application (2025-2030)
5.2.3 Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Application (2019-2030)
5.3 Global Orally Disintegrating Tablets (ODT) Platform Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Catalent
6.1.1 Catalent Company Information
6.1.2 Catalent Description and Business Overview
6.1.3 Catalent Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Catalent Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.1.5 Catalent Recent Developments/Updates
6.2 SPI Pharma
6.2.1 SPI Pharma Company Information
6.2.2 SPI Pharma Description and Business Overview
6.2.3 SPI Pharma Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SPI Pharma Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.2.5 SPI Pharma Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Company Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Pharmaceutical Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 Fuisz Technologies
6.4.1 Fuisz Technologies Company Information
6.4.2 Fuisz Technologies Description and Business Overview
6.4.3 Fuisz Technologies Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fuisz Technologies Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.4.5 Fuisz Technologies Recent Developments/Updates
6.5 Roquette
6.5.1 Roquette Company Information
6.5.2 Roquette Description and Business Overview
6.5.3 Roquette Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roquette Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.5.5 Roquette Recent Developments/Updates
6.6 JRS Pharma
6.6.1 JRS Pharma Company Information
6.6.2 JRS Pharma Description and Business Overview
6.6.3 JRS Pharma Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JRS Pharma Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.6.5 JRS Pharma Recent Developments/Updates
6.7 Fuji Chemical
6.7.1 Fuji Chemical Company Information
6.7.2 Fuji Chemical Description and Business Overview
6.7.3 Fuji Chemical Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Fuji Chemical Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.7.5 Fuji Chemical Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Galvita
6.9.1 Galvita Company Information
6.9.2 Galvita Description and Business Overview
6.9.3 Galvita Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Galvita Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.9.5 Galvita Recent Developments/Updates
6.10 DAICEL
6.10.1 DAICEL Company Information
6.10.2 DAICEL Description and Business Overview
6.10.3 DAICEL Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.10.4 DAICEL Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.10.5 DAICEL Recent Developments/Updates
6.11 BASF
6.11.1 BASF Company Information
6.11.2 BASF Description and Business Overview
6.11.3 BASF Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BASF Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.11.5 BASF Recent Developments/Updates
6.12 Adare Pharma
6.12.1 Adare Pharma Company Information
6.12.2 Adare Pharma Description and Business Overview
6.12.3 Adare Pharma Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Adare Pharma Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.12.5 Adare Pharma Recent Developments/Updates
6.13 Astellas Pharma
6.13.1 Astellas Pharma Company Information
6.13.2 Astellas Pharma Description and Business Overview
6.13.3 Astellas Pharma Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Astellas Pharma Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.13.5 Astellas Pharma Recent Developments/Updates
6.14 Akina
6.14.1 Akina Company Information
6.14.2 Akina Description and Business Overview
6.14.3 Akina Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Akina Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.14.5 Akina Recent Developments/Updates
6.15 Vitaquest
6.15.1 Vitaquest Company Information
6.15.2 Vitaquest Description and Business Overview
6.15.3 Vitaquest Orally Disintegrating Tablets (ODT) Platform Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Vitaquest Orally Disintegrating Tablets (ODT) Platform Product Portfolio
6.15.5 Vitaquest Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablets (ODT) Platform Industry Chain Analysis
7.2 Orally Disintegrating Tablets (ODT) Platform Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablets (ODT) Platform Production Mode & Process
7.4 Orally Disintegrating Tablets (ODT) Platform Sales and Marketing
7.4.1 Orally Disintegrating Tablets (ODT) Platform Sales Channels
7.4.2 Orally Disintegrating Tablets (ODT) Platform Distributors
7.5 Orally Disintegrating Tablets (ODT) Platform Customers
8 Orally Disintegrating Tablets (ODT) Platform Market Dynamics
8.1 Orally Disintegrating Tablets (ODT) Platform Industry Trends
8.2 Orally Disintegrating Tablets (ODT) Platform Market Drivers
8.3 Orally Disintegrating Tablets (ODT) Platform Market Challenges
8.4 Orally Disintegrating Tablets (ODT) Platform Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Orally Disintegrating Tablets (ODT) Platform Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Orally Disintegrating Tablets (ODT) Platform Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Orally Disintegrating Tablets (ODT) Platform Market Competitive Situation by Manufacturers in 2023
Table 4. Global Orally Disintegrating Tablets (ODT) Platform Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Orally Disintegrating Tablets (ODT) Platform Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Orally Disintegrating Tablets (ODT) Platform Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Orally Disintegrating Tablets (ODT) Platform Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Orally Disintegrating Tablets (ODT) Platform, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Orally Disintegrating Tablets (ODT) Platform, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orally Disintegrating Tablets (ODT) Platform, Product Type & Application
Table 12. Global Key Manufacturers of Orally Disintegrating Tablets (ODT) Platform, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Disintegrating Tablets (ODT) Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablets (ODT) Platform as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orally Disintegrating Tablets (ODT) Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Orally Disintegrating Tablets (ODT) Platform Sales by Region (2019-2024) & (K Dose)
Table 18. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Region (2019-2024)
Table 19. Global Orally Disintegrating Tablets (ODT) Platform Sales by Region (2025-2030) & (K Dose)
Table 20. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Region (2025-2030)
Table 21. Global Orally Disintegrating Tablets (ODT) Platform Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Region (2019-2024)
Table 23. Global Orally Disintegrating Tablets (ODT) Platform Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Region (2025-2030)
Table 25. North America Orally Disintegrating Tablets (ODT) Platform Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2024) & (K Dose)
Table 27. North America Orally Disintegrating Tablets (ODT) Platform Sales by Country (2025-2030) & (K Dose)
Table 28. North America Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Orally Disintegrating Tablets (ODT) Platform Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Orally Disintegrating Tablets (ODT) Platform Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Orally Disintegrating Tablets (ODT) Platform Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Orally Disintegrating Tablets (ODT) Platform Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Orally Disintegrating Tablets (ODT) Platform Sales (K Dose) by Type (2019-2024)
Table 51. Global Orally Disintegrating Tablets (ODT) Platform Sales (K Dose) by Type (2025-2030)
Table 52. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Type (2019-2024)
Table 53. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Type (2025-2030)
Table 54. Global Orally Disintegrating Tablets (ODT) Platform Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Orally Disintegrating Tablets (ODT) Platform Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Type (2019-2024)
Table 57. Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Type (2025-2030)
Table 58. Global Orally Disintegrating Tablets (ODT) Platform Price (US$/Dose) by Type (2019-2024)
Table 59. Global Orally Disintegrating Tablets (ODT) Platform Price (US$/Dose) by Type (2025-2030)
Table 60. Global Orally Disintegrating Tablets (ODT) Platform Sales (K Dose) by Application (2019-2024)
Table 61. Global Orally Disintegrating Tablets (ODT) Platform Sales (K Dose) by Application (2025-2030)
Table 62. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Application (2019-2024)
Table 63. Global Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Application (2025-2030)
Table 64. Global Orally Disintegrating Tablets (ODT) Platform Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Orally Disintegrating Tablets (ODT) Platform Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Application (2019-2024)
Table 67. Global Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Application (2025-2030)
Table 68. Global Orally Disintegrating Tablets (ODT) Platform Price (US$/Dose) by Application (2019-2024)
Table 69. Global Orally Disintegrating Tablets (ODT) Platform Price (US$/Dose) by Application (2025-2030)
Table 70. Catalent Company Information
Table 71. Catalent Description and Business Overview
Table 72. Catalent Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Catalent Orally Disintegrating Tablets (ODT) Platform Product
Table 74. Catalent Recent Developments/Updates
Table 75. SPI Pharma Company Information
Table 76. SPI Pharma Description and Business Overview
Table 77. SPI Pharma Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. SPI Pharma Orally Disintegrating Tablets (ODT) Platform Product
Table 79. SPI Pharma Recent Developments/Updates
Table 80. Takeda Pharmaceutical Company Information
Table 81. Takeda Pharmaceutical Description and Business Overview
Table 82. Takeda Pharmaceutical Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Takeda Pharmaceutical Orally Disintegrating Tablets (ODT) Platform Product
Table 84. Takeda Pharmaceutical Recent Developments/Updates
Table 85. Fuisz Technologies Company Information
Table 86. Fuisz Technologies Description and Business Overview
Table 87. Fuisz Technologies Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Fuisz Technologies Orally Disintegrating Tablets (ODT) Platform Product
Table 89. Fuisz Technologies Recent Developments/Updates
Table 90. Roquette Company Information
Table 91. Roquette Description and Business Overview
Table 92. Roquette Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Roquette Orally Disintegrating Tablets (ODT) Platform Product
Table 94. Roquette Recent Developments/Updates
Table 95. JRS Pharma Company Information
Table 96. JRS Pharma Description and Business Overview
Table 97. JRS Pharma Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. JRS Pharma Orally Disintegrating Tablets (ODT) Platform Product
Table 99. JRS Pharma Recent Developments/Updates
Table 100. Fuji Chemical Company Information
Table 101. Fuji Chemical Description and Business Overview
Table 102. Fuji Chemical Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Fuji Chemical Orally Disintegrating Tablets (ODT) Platform Product
Table 104. Fuji Chemical Recent Developments/Updates
Table 105. Merck Company Information
Table 106. Merck Description and Business Overview
Table 107. Merck Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Merck Orally Disintegrating Tablets (ODT) Platform Product
Table 109. Merck Recent Developments/Updates
Table 110. Galvita Company Information
Table 111. Galvita Description and Business Overview
Table 112. Galvita Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Galvita Orally Disintegrating Tablets (ODT) Platform Product
Table 114. Galvita Recent Developments/Updates
Table 115. DAICEL Company Information
Table 116. DAICEL Description and Business Overview
Table 117. DAICEL Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. DAICEL Orally Disintegrating Tablets (ODT) Platform Product
Table 119. DAICEL Recent Developments/Updates
Table 120. BASF Company Information
Table 121. BASF Description and Business Overview
Table 122. BASF Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. BASF Orally Disintegrating Tablets (ODT) Platform Product
Table 124. BASF Recent Developments/Updates
Table 125. Adare Pharma Company Information
Table 126. Adare Pharma Description and Business Overview
Table 127. Adare Pharma Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Adare Pharma Orally Disintegrating Tablets (ODT) Platform Product
Table 129. Adare Pharma Recent Developments/Updates
Table 130. Astellas Pharma Company Information
Table 131. Astellas Pharma Description and Business Overview
Table 132. Astellas Pharma Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. Astellas Pharma Orally Disintegrating Tablets (ODT) Platform Product
Table 134. Astellas Pharma Recent Developments/Updates
Table 135. Akina Company Information
Table 136. Akina Description and Business Overview
Table 137. Akina Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 138. Akina Orally Disintegrating Tablets (ODT) Platform Product
Table 139. Akina Recent Developments/Updates
Table 140. Vitaquest Company Information
Table 141. Vitaquest Description and Business Overview
Table 142. Vitaquest Orally Disintegrating Tablets (ODT) Platform Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 143. Vitaquest Orally Disintegrating Tablets (ODT) Platform Product
Table 144. Vitaquest Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Orally Disintegrating Tablets (ODT) Platform Distributors List
Table 148. Orally Disintegrating Tablets (ODT) Platform Customers List
Table 149. Orally Disintegrating Tablets (ODT) Platform Market Trends
Table 150. Orally Disintegrating Tablets (ODT) Platform Market Drivers
Table 151. Orally Disintegrating Tablets (ODT) Platform Market Challenges
Table 152. Orally Disintegrating Tablets (ODT) Platform Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Orally Disintegrating Tablets (ODT) Platform
Figure 2. Global Orally Disintegrating Tablets (ODT) Platform Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Orally Disintegrating Tablets (ODT) Platform Market Share by Type: 2023 & 2030
Figure 4. Below Ten Seconds Product Picture
Figure 5. Ten Seconds and Above Product Picture
Figure 6. Global Orally Disintegrating Tablets (ODT) Platform Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Orally Disintegrating Tablets (ODT) Platform Market Share by Application: 2023 & 2030
Figure 8. Pharmaceutical
Figure 9. Nutraceuticals
Figure 10. Chewable Vitamin
Figure 11. Global Orally Disintegrating Tablets (ODT) Platform Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Orally Disintegrating Tablets (ODT) Platform Market Size (2019-2030) & (US$ Million)
Figure 13. Global Orally Disintegrating Tablets (ODT) Platform Sales (2019-2030) & (K Dose)
Figure 14. Global Orally Disintegrating Tablets (ODT) Platform Average Price (US$/Dose) & (2019-2030)
Figure 15. Orally Disintegrating Tablets (ODT) Platform Report Years Considered
Figure 16. Orally Disintegrating Tablets (ODT) Platform Sales Share by Manufacturers in 2023
Figure 17. Global Orally Disintegrating Tablets (ODT) Platform Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Orally Disintegrating Tablets (ODT) Platform Players: Market Share by Revenue in Orally Disintegrating Tablets (ODT) Platform in 2023
Figure 19. Orally Disintegrating Tablets (ODT) Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Orally Disintegrating Tablets (ODT) Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Country (2019-2030)
Figure 22. North America Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Country (2019-2030)
Figure 23. United States Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Country (2019-2030)
Figure 26. Europe Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Country (2019-2030)
Figure 27. Germany Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Region (2019-2030)
Figure 34. China Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Country (2019-2030)
Figure 42. Mexico Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Orally Disintegrating Tablets (ODT) Platform Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Orally Disintegrating Tablets (ODT) Platform Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Orally Disintegrating Tablets (ODT) Platform by Type (2019-2030)
Figure 52. Global Revenue Market Share of Orally Disintegrating Tablets (ODT) Platform by Type (2019-2030)
Figure 53. Global Orally Disintegrating Tablets (ODT) Platform Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Orally Disintegrating Tablets (ODT) Platform by Application (2019-2030)
Figure 55. Global Revenue Market Share of Orally Disintegrating Tablets (ODT) Platform by Application (2019-2030)
Figure 56. Global Orally Disintegrating Tablets (ODT) Platform Price (US$/Dose) by Application (2019-2030)
Figure 57. Orally Disintegrating Tablets (ODT) Platform Value Chain
Figure 58. Orally Disintegrating Tablets (ODT) Platform Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
